China pledges stronger reform on approving, monitoring new drugs

23 March 2019 - China pledged to improve its system for registering new drugs in the country this year and ...

Read more →

Senate panel to hear from pharmacy middlemen on drug prices

21 March 2019 - The Senate Finance Committee said Thursday that it has secured commitments from executives of five major ...

Read more →

Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

Biosimilar groups offer proposals to help US better mirror EU successes

19 March 2019 - With 18 biosimilars approved in the US and just seven on the market, two biosimilars groups ...

Read more →

Biosimilar approval and adoption in the U.S. needs to be expedited

20 March 2019 - Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. ...

Read more →

Senate bill endorses Azar's call to allow drug imports

20 March 2019 - Bipartisan support for a Senate bill that seeks to allow drug importation to boost competition dovetails ...

Read more →

FDA reform: it’s time to act, but not as an independent agency

19 March 2019 - In a rare exercise in bipartisan leadership, former FDA commissioners of both political parties called, in ...

Read more →

Partisan squabbles shadow Congress' efforts to lower drug prices

20 March 2019 - It was supposed to be one of the few areas of bipartisanship. ...

Read more →

Biosimilars Forum and Medicines for Europe call for changes to the US biosimilars market

19 March 2019 - The Biosimilars Forum and Medicines for Europe today released a joint white paper that discusses how Europe ...

Read more →

Washington must change the system that encourages high drug prices

18 March 2019 -“Take away our rebates? We’ll just up premiums.”  ...

Read more →

Chile takes several ‘unorthodox’ steps to push back on drug prices, angering pharma

18 March 2019 - Searching for ways to beat back rising drug costs, the Chilean legislature is advancing three measures ...

Read more →

The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs

18 March 2019 - The resignation of Scott Gottlieb as commissioner of the Food and Drug Administration raises a big ...

Read more →

CMA drops anti-competitive case against MSD

18 March 2019 - The Competition and Markets Authority has closed its investigation into a suspected anti-competitive discount scheme developed ...

Read more →

What 1 April 2019 private health insurance changes mean for you

17 March 2019 - When the calendar flips to April 1 this year, many private health insurance customers will need ...

Read more →

Statement from FDA Commissioner and Director of the Center for Devices and Radiological Health on efforts to evaluate materials in medical devices to address potential safety questions

15 March 2019 - We’re in an unprecedented era of innovation in medical devices with advances in materials science that ...

Read more →